{"name":"Galderma R&D","slug":"galderma-r-d","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":35,"colorKey":"immunology","drugs":[{"name":"BPO","genericName":"BPO","slug":"bpo","indication":"Acne vulgaris (mild to moderate)","status":"marketed"},{"name":"Epiduo/Tactuo","genericName":"Epiduo/Tactuo","slug":"epiduo-tactuo","indication":"Acne vulgaris","status":"phase_3"},{"name":"\"Cetaphil Healing Ointment\"","genericName":"\"Cetaphil Healing Ointment\"","slug":"cetaphil-healing-ointment","indication":"Minor cuts, scrapes, and wounds","status":"marketed"},{"name":"ABPO Forte Gel","genericName":"ABPO Forte Gel","slug":"abpo-forte-gel","indication":"Acne vulgaris","status":"marketed"},{"name":"Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel","genericName":"Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel","slug":"adapalene-0-1-benzoyl-peroxide-2-5-gel","indication":"Acne vulgaris","status":"phase_3"},{"name":"Adapalene 0.3% / BPO 2.5% gel","genericName":"Adapalene 0.3% / BPO 2.5% gel","slug":"adapalene-0-3-bpo-2-5-gel","indication":"Acne vulgaris","status":"phase_3"},{"name":"Adapalene BPO","genericName":"Adapalene BPO","slug":"adapalene-bpo","indication":"Acne vulgaris","status":"phase_3"},{"name":"Adapalene Gel, 0.1%","genericName":"Adapalene Gel, 0.1%","slug":"adapalene-gel-0-1","indication":"Acne vulgaris","status":"marketed"},{"name":"Adapalene Gel, 0.1% + Tazarotene Cream, 0.1%","genericName":"Adapalene Gel, 0.1% + Tazarotene Cream, 0.1%","slug":"adapalene-gel-0-1-tazarotene-cream-0-1","indication":"Acne vulgaris","status":"marketed"},{"name":"Adapalene Lotion Vehicle","genericName":"Adapalene Lotion Vehicle","slug":"adapalene-lotion-vehicle","indication":"Acne vulgaris","status":"phase_3"},{"name":"Adapalene/benzoyl peroxide gel, 0.1%/2.5%","genericName":"Adapalene/benzoyl peroxide gel, 0.1%/2.5%","slug":"adapalene-benzoyl-peroxide-gel-0-1-2-5","indication":"Acne vulgaris","status":"marketed"},{"name":"Benzoyl Peroxide Gel 2.5%","genericName":"Benzoyl Peroxide Gel 2.5%","slug":"benzoyl-peroxide-gel-2-5","indication":"Acne vulgaris","status":"phase_3"},{"name":"CD0271 0.1% / CD1579 2.5%","genericName":"CD0271 0.1% / CD1579 2.5%","slug":"cd0271-0-1-cd1579-2-5","indication":"Dermatological inflammatory condition (specific indication not publicly disclosed)","status":"phase_3"},{"name":"CD0271 0.3% / CD1579 2.5%","genericName":"CD0271 0.3% / CD1579 2.5%","slug":"cd0271-0-3-cd1579-2-5","indication":"Inflammatory dermatological condition (specific indication not publicly disclosed)","status":"phase_3"},{"name":"CD07805/47 gel","genericName":"CD07805/47 gel","slug":"cd07805-47-gel","indication":"Acne vulgaris","status":"phase_3"},{"name":"CD07805/47 gel 0.5%/CD07805/47 Vehicle","genericName":"CD07805/47 gel 0.5%/CD07805/47 Vehicle","slug":"cd07805-47-gel-0-5-cd07805-47-vehicle","indication":"Acne vulgaris","status":"phase_3"},{"name":"CD10367 1% Solution - Non-desquamated zone","genericName":"CD10367 1% Solution - Non-desquamated zone","slug":"cd10367-1-solution-non-desquamated-zone","indication":"Non-desquamated skin lesions (Phase 2)","status":"phase_2"},{"name":"CD10367 3% Solution - Non-desquamated zone","genericName":"CD10367 3% Solution - Non-desquamated zone","slug":"cd10367-3-solution-non-desquamated-zone","indication":"Acne vulgaris","status":"phase_2"},{"name":"CD11301 0.06%","genericName":"CD11301 0.06%","slug":"cd11301-0-06","indication":"Acne vulgaris","status":"phase_2"},{"name":"CD1579 5%","genericName":"CD1579 5%","slug":"cd1579-5","indication":"Acne vulgaris","status":"phase_2"},{"name":"CD5024 0.3% cream","genericName":"CD5024 0.3% cream","slug":"cd5024-0-3-cream","indication":"Atopic dermatitis","status":"phase_2"},{"name":"Clobex® Vehicle Shampoo","genericName":"Clobex® Vehicle Shampoo","slug":"clobex-vehicle-shampoo","indication":"Inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp","status":"phase_3"},{"name":"Drug: CD07805/47 gel","genericName":"Drug: CD07805/47 gel","slug":"drug-cd07805-47-gel","indication":"Photoaged skin and facial wrinkles","status":"phase_3"},{"name":"Lidocaine 7% + Tetracaine 7% cream","genericName":"Lidocaine 7% + Tetracaine 7% cream","slug":"lidocaine-7-tetracaine-7-cream","indication":"Topical anesthesia for dermatological procedures (e.g., laser treatment, chemical peels, microdermabrasion)","status":"marketed"},{"name":"MAL Vehicle Cream","genericName":"MAL Vehicle Cream","slug":"mal-vehicle-cream","indication":"Topical delivery vehicle for dermatological applications (specific indication dependent on active ingredient formulated with this vehicle)","status":"phase_3"},{"name":"QM1114-DP","genericName":"QM1114-DP","slug":"qm1114-dp","indication":"Acne vulgaris","status":"phase_3"},{"name":"Retin-A Micro Microsphere 0.1%","genericName":"Retin-A Micro Microsphere 0.1%","slug":"retin-a-micro-microsphere-0-1","indication":"Acne vulgaris","status":"marketed"},{"name":"Trifarotene Vehicle","genericName":"Trifarotene Vehicle","slug":"trifarotene-vehicle","indication":"Acne vulgaris","status":"marketed"},{"name":"Trifarotene cream","genericName":"Trifarotene cream","slug":"trifarotene-cream","indication":"Acne vulgaris","status":"marketed"},{"name":"adapalene gel, 0.3%","genericName":"adapalene gel, 0.3%","slug":"adapalene-gel-0-3","indication":"Acne vulgaris","status":"marketed"},{"name":"adapalene lotion 0.1%","genericName":"adapalene lotion 0.1%","slug":"adapalene-lotion-0-1","indication":"Acne vulgaris","status":"phase_3"},{"name":"adapalene/benzoyl peroxide","genericName":"adapalene/benzoyl peroxide","slug":"adapalene-benzoyl-peroxide","indication":"Acne vulgaris","status":"marketed"},{"name":"azelaic acid 15% gel","genericName":"azelaic acid 15% gel","slug":"azelaic-acid-15-gel","indication":"Acne vulgaris","status":"marketed"},{"name":"ketoconazole shampoo (2/week)","genericName":"ketoconazole shampoo (2/week)","slug":"ketoconazole-shampoo-2-week","indication":"Dandruff and seborrheic dermatitis of the scalp","status":"phase_3"},{"name":"tretinoin 0.05% emollient cream","genericName":"tretinoin 0.05% emollient cream","slug":"tretinoin-0-05-emollient-cream","indication":"Acne vulgaris","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":21,"colorKey":"oncology","drugs":[{"name":"Azzalure","genericName":"Azzalure","slug":"azzalure","indication":"Other","status":"marketed"},{"name":"CYP 450 Substrates","genericName":"CYP 450 Substrates","slug":"cyp-450-substrates","indication":"Other","status":"phase_2"},{"name":"Cetaphil","genericName":"Cetaphil","slug":"cetaphil","indication":"Other","status":"marketed"},{"name":"Product A","genericName":"Product A","slug":"product-a","indication":"Other","status":"marketed"},{"name":"AbobotulinumtoxinA dose 1","genericName":"AbobotulinumtoxinA dose 1","slug":"abobotulinumtoxina-dose-1","indication":"Glabellar lines","status":"phase_2"},{"name":"AbobotulinumtoxinA dose level 1 or 2","genericName":"AbobotulinumtoxinA dose level 1 or 2","slug":"abobotulinumtoxina-dose-level-1-or-2","indication":"Glabellar lines","status":"phase_2"},{"name":"Adapalene 0.1% and Benzoyl Peroxide 2.5% gel","genericName":"Adapalene 0.1% and Benzoyl Peroxide 2.5% gel","slug":"adapalene-0-1-and-benzoyl-peroxide-2-5-gel","indication":"Other","status":"marketed"},{"name":"Alluzience","genericName":"Alluzience","slug":"alluzience","indication":"Other","status":"marketed"},{"name":"Betneval ointment - Non-desquamated zone","genericName":"Betneval ointment - Non-desquamated zone","slug":"betneval-ointment-non-desquamated-zone","indication":"Other","status":"phase_2"},{"name":"Botulinum Toxin Type A - Vistabel","genericName":"Botulinum Toxin Type A - Vistabel","slug":"botulinum-toxin-type-a-vistabel","indication":"Frown lines","status":"phase_2"},{"name":"Brimonidine 0.33% gel (Br)","genericName":"Brimonidine 0.33% gel (Br)","slug":"brimonidine-0-33-gel-br","indication":"Persistent facial erythema associated with rosacea","status":"marketed"},{"name":"CD 2027","genericName":"CD 2027","slug":"cd-2027","indication":"Other","status":"phase_2"},{"name":"CD10367 3% Solution - Desquamated zone","genericName":"CD10367 3% Solution - Desquamated zone","slug":"cd10367-3-solution-desquamated-zone","indication":"Treatment of desquamation","status":"phase_2"},{"name":"CD11301 0.03%","genericName":"CD11301 0.03%","slug":"cd11301-0-03","indication":"Other","status":"phase_2"},{"name":"Facial Cleanser and Moisturizer SPF 30","genericName":"Facial Cleanser and Moisturizer SPF 30","slug":"facial-cleanser-and-moisturizer-spf-30","indication":"Daily facial cleansing and sun protection (SPF 30)","status":"marketed"},{"name":"Facial Moisturizer with SPF 50+","genericName":"Facial Moisturizer with SPF 50+","slug":"facial-moisturizer-with-spf-50","indication":"Sun protection and photoaging prevention","status":"marketed"},{"name":"Ivermectin 1% cream (IVM)","genericName":"Ivermectin 1% cream (IVM)","slug":"ivermectin-1-cream-ivm","indication":"Rosacea (topical)","status":"marketed"},{"name":"Oracea","genericName":"Oracea","slug":"oracea","indication":"Other","status":"marketed"},{"name":"Product B","genericName":"Product B","slug":"product-b","indication":"Other","status":"marketed"},{"name":"adapalen 0.1%","genericName":"adapalen 0.1%","slug":"adapalen-0-1","indication":"Other","status":"marketed"},{"name":"adapalene cream 0.1% and adapalene lotion 0.1%","genericName":"adapalene cream 0.1% and adapalene lotion 0.1%","slug":"adapalene-cream-0-1-and-adapalene-lotion-0-1","indication":"Other","status":"phase_1"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":16,"colorKey":"cardiovascular","drugs":[{"name":"CD1579","genericName":"CD1579","slug":"cd1579","indication":"Atopic dermatitis","status":"phase_3"},{"name":"Clobex Spray","genericName":"Clobex Spray","slug":"clobex-spray","indication":"Inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses (e.g., psoriasis, lichen planus, atopic dermatitis)","status":"marketed"},{"name":"Clobex® Shampoo","genericName":"Clobex® Shampoo","slug":"clobex-shampoo","indication":"Scalp psoriasis","status":"phase_3"},{"name":"Tazarotene 0.1% gel","genericName":"Tazarotene 0.1% gel","slug":"tazarotene-0-1-gel","indication":"Acne vulgaris","status":"marketed"},{"name":"Tazarotene Cream, 0.1%","genericName":"Tazarotene Cream, 0.1%","slug":"tazarotene-cream-0-1","indication":"Plaque psoriasis","status":"marketed"},{"name":"C. propionate - Corticosteroid 1","genericName":"C. propionate - Corticosteroid 1","slug":"c-propionate-corticosteroid-1","indication":"Inflammatory and pruritic dermatological conditions (e.g., psoriasis, eczema, lichen planus, dermatitis)","status":"phase_3"},{"name":"C. propionate -Corticosteroid 3","genericName":"C. propionate -Corticosteroid 3","slug":"c-propionate-corticosteroid-3","indication":"Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., psoriasis, lichen planus, severe eczema)","status":"phase_3"},{"name":"C. propionate- Corticosteroid 2","genericName":"C. propionate- Corticosteroid 2","slug":"c-propionate-corticosteroid-2","indication":"Severe inflammatory dermatological conditions (e.g., severe psoriasis, lichen planus, severe eczema)","status":"phase_3"},{"name":"CD0271","genericName":"CD0271","slug":"cd0271","indication":"Atopic dermatitis","status":"phase_3"},{"name":"CD5789 (trifarotene)","genericName":"CD5789 (trifarotene)","slug":"cd5789-trifarotene","indication":"Psoriasis","status":"phase_3"},{"name":"Calcipotriene and betamethasone dipropionate ointment","genericName":"Calcipotriene and betamethasone dipropionate ointment","slug":"calcipotriene-and-betamethasone-dipropionate-ointment","indication":"Plaque psoriasis","status":"marketed"},{"name":"Clobetasol Propionate 0.05% Foam","genericName":"Clobetasol Propionate 0.05% Foam","slug":"clobetasol-propionate-0-05-foam","indication":"Inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses (scalp and body)","status":"marketed"},{"name":"Clobetasol Propionate, 0.05%","genericName":"Clobetasol Propionate, 0.05%","slug":"clobetasol-propionate-0-05","indication":"Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., psoriasis, lichen planus, severe eczema)","status":"marketed"},{"name":"Corticosteroid 1- C. propionate","genericName":"Corticosteroid 1- C. propionate","slug":"corticosteroid-1-c-propionate","indication":"Severe inflammatory dermatological conditions (e.g., severe psoriasis, lichen planus, severe eczema)","status":"phase_3"},{"name":"Corticosteroid 2 - C. propionate","genericName":"Corticosteroid 2 - C. propionate","slug":"corticosteroid-2-c-propionate","indication":"Severe inflammatory dermatological conditions (e.g., severe psoriasis, lichen planus, severe eczema)","status":"phase_3"},{"name":"Corticosteroid 3 - C. propionate","genericName":"Corticosteroid 3 - C. propionate","slug":"corticosteroid-3-c-propionate","indication":"Severe inflammatory dermatological conditions (e.g., severe psoriasis, lichen planus, severe eczema)","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":10,"colorKey":"respiratory","drugs":[{"name":"Bifonazole Cream","genericName":"Bifonazole Cream","slug":"bifonazole-cream","indication":"Fungal skin infections including dermatophytosis, candidiasis, and pityriasis versicolor","status":"marketed"},{"name":"Ciclopirox NL","genericName":"Ciclopirox NL","slug":"ciclopirox-nl","indication":"Onychomycosis (fungal nail infection)","status":"marketed"},{"name":"Loceryl NL","genericName":"Loceryl NL","slug":"loceryl-nl","indication":"Onychomycosis (fungal nail infection)","status":"marketed"},{"name":"Loceryl NL + Cosmetic varnish","genericName":"Loceryl NL + Cosmetic varnish","slug":"loceryl-nl-cosmetic-varnish","indication":"Onychomycosis (fungal nail infection)","status":"marketed"},{"name":"Loceryl NL 12 weeks","genericName":"Loceryl NL 12 weeks","slug":"loceryl-nl-12-weeks","indication":"Onychomycosis (fungal nail infection)","status":"marketed"},{"name":"Loceryl NL 15 months","genericName":"Loceryl NL 15 months","slug":"loceryl-nl-15-months","indication":"Onychomycosis (fungal nail infection) of toenails and fingernails","status":"marketed"},{"name":"Loceryl Nail Lacquer","genericName":"Loceryl Nail Lacquer","slug":"loceryl-nail-lacquer","indication":"Onychomycosis (fungal nail infection) caused by dermatophytes, yeasts, and non-dermatophyte molds","status":"marketed"},{"name":"Metronidazole 0.75% cream","genericName":"Metronidazole 0.75% cream","slug":"metronidazole-0-75-cream","indication":"Rosacea (topical treatment)","status":"phase_3"},{"name":"Metronidazole gel 1%","genericName":"Metronidazole gel 1%","slug":"metronidazole-gel-1","indication":"Rosacea (topical)","status":"marketed"},{"name":"Oral doxycycline hyclate","genericName":"Oral doxycycline hyclate","slug":"oral-doxycycline-hyclate","indication":"Bacterial infections (respiratory, urinary, skin, soft tissue)","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":8,"colorKey":"rare","drugs":[{"name":"CD07223","genericName":"CD07223","slug":"cd07223","indication":"Metastatic melanoma","status":"phase_2"},{"name":"MAL 16.8% cream","genericName":"MAL 16.8% cream","slug":"mal-16-8-cream","indication":"Actinic keratosis (field treatment)","status":"phase_3"},{"name":"Methyl Aminolaevulinate 16% Cream","genericName":"Methyl Aminolaevulinate 16% Cream","slug":"methyl-aminolaevulinate-16-cream","indication":"Actinic keratosis (non-hyperkeratotic, non-pigmented lesions on face and scalp)","status":"marketed"},{"name":"Metvix and conventional PDT","genericName":"Metvix and conventional PDT","slug":"metvix-and-conventional-pdt","indication":"Actinic keratosis","status":"phase_3"},{"name":"Metvix and natural daylight PDT","genericName":"Metvix and natural daylight PDT","slug":"metvix-and-natural-daylight-pdt","indication":"Actinic keratosis (field treatment with daylight PDT)","status":"phase_3"},{"name":"Metvix cream","genericName":"Metvix cream","slug":"metvix-cream","indication":"Actinic keratosis","status":"phase_3"},{"name":"NDL-PDT","genericName":"NDL-PDT","slug":"ndl-pdt","indication":"Actinic keratosis","status":"phase_3"},{"name":"c-PDT","genericName":"c-PDT","slug":"c-pdt","indication":"Actinic keratosis","status":"phase_3"}]},{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"infectious","drugs":[{"name":"Advanced Eye Relief","genericName":"Advanced Eye Relief","slug":"advanced-eye-relief","indication":"Minor eye irritation and redness","status":"marketed"},{"name":"Azzalure or Dysport","genericName":"Azzalure or Dysport","slug":"azzalure-or-dysport","indication":"Moderate to severe glabellar lines (frown lines between eyebrows)","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"metabolic","drugs":[{"name":"botulinum toxin neuromodulator","genericName":"botulinum toxin neuromodulator","slug":"botulinum-toxin-neuromodulator","indication":"Chronic migraine","status":"phase_3"},{"name":"powder BoNT-A (BOTOX/Vistabel)","genericName":"powder BoNT-A (BOTOX/Vistabel)","slug":"powder-bont-a-botox-vistabel","indication":"Moderate to severe glabellar lines (frown lines) in adults","status":"marketed"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"GK567","genericName":"GK567","slug":"gk567","indication":"Type 2 diabetes mellitus","status":"phase_3"}]}],"pipeline":[{"name":"Azzalure","genericName":"Azzalure","slug":"azzalure","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BPO","genericName":"BPO","slug":"bpo","phase":"marketed","mechanism":"BPO (benzoyl peroxide) kills acne-causing bacteria and reduces sebum production while promoting skin cell turnover.","indications":["Acne vulgaris (mild to moderate)","Acne rosacea (adjunctive)"],"catalyst":""},{"name":"CD1579","genericName":"CD1579","slug":"cd1579","phase":"phase_3","mechanism":"CD1579 is a selective inhibitor of phosphodiesterase 4 (PDE4) that reduces inflammatory mediator production in immune cells.","indications":["Atopic dermatitis","Psoriasis"],"catalyst":""},{"name":"CYP 450 Substrates","genericName":"CYP 450 Substrates","slug":"cyp-450-substrates","phase":"phase_2","mechanism":"CYP 450 substrates inhibit the activity of the cytochrome P450 enzyme system.","indications":[],"catalyst":""},{"name":"Cetaphil","genericName":"Cetaphil","slug":"cetaphil","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Clobex Spray","genericName":"Clobex Spray","slug":"clobex-spray","phase":"marketed","mechanism":"Clobex Spray is a potent topical corticosteroid that suppresses inflammatory and immune responses in the skin.","indications":["Inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses (e.g., psoriasis, lichen planus, atopic dermatitis)","Severe inflammatory skin conditions requiring potent topical corticosteroid therapy"],"catalyst":""},{"name":"Clobex® Shampoo","genericName":"Clobex® Shampoo","slug":"clobex-shampoo","phase":"phase_3","mechanism":"Clobetasol propionate is a potent topical corticosteroid that suppresses inflammatory and immune responses in the skin.","indications":["Scalp psoriasis","Seborrheic dermatitis of the scalp","Other inflammatory scalp conditions responsive to topical corticosteroids"],"catalyst":""},{"name":"Epiduo/Tactuo","genericName":"Epiduo/Tactuo","slug":"epiduo-tactuo","phase":"phase_3","mechanism":"Epiduo/Tactuo combines adapalene (a retinoid) and benzoyl peroxide to reduce acne by normalizing skin cell turnover and killing acne-causing bacteria.","indications":["Acne vulgaris"],"catalyst":""},{"name":"GK567","genericName":"GK567","slug":"gk567","phase":"phase_3","mechanism":"GK567 is a glucokinase activator that enhances glucose metabolism in pancreatic beta cells to stimulate insulin secretion.","indications":["Type 2 diabetes mellitus"],"catalyst":""},{"name":"Product A","genericName":"Product A","slug":"product-a","phase":"marketed","mechanism":"Product A is a marketed pharmaceutical from Galderma R&D, but specific mechanistic details are not provided.","indications":[],"catalyst":""},{"name":"Tazarotene 0.1% gel","genericName":"Tazarotene 0.1% gel","slug":"tazarotene-0-1-gel","phase":"marketed","mechanism":"Tazarotene is a retinoid that binds to retinoid X receptors (RXR) and retinoid acid receptors (RAR) to regulate gene expression and promote skin cell differentiation and turnover.","indications":["Acne vulgaris","Plaque psoriasis","Photoaging and facial wrinkles"],"catalyst":""},{"name":"Tazarotene Cream, 0.1%","genericName":"Tazarotene Cream, 0.1%","slug":"tazarotene-cream-0-1","phase":"marketed","mechanism":"Tazarotene is a retinoid that binds to retinoid X receptors (RXR) and retinoid acid receptors (RAR) to regulate gene expression and reduce skin inflammation and abnormal keratinocyte differentiation.","indications":["Plaque psoriasis","Acne vulgaris","Photoaging and photodamaged skin"],"catalyst":""},{"name":"\"Cetaphil Healing Ointment\"","genericName":"\"Cetaphil Healing Ointment\"","slug":"cetaphil-healing-ointment","phase":"marketed","mechanism":"Cetaphil Healing Ointment creates a protective barrier on the skin while providing emollient and humectant ingredients to promote wound healing and skin repair.","indications":["Minor cuts, scrapes, and wounds","Dry, irritated, or sensitive skin","Post-procedure skin healing"],"catalyst":""},{"name":"ABPO Forte Gel","genericName":"ABPO Forte Gel","slug":"abpo-forte-gel","phase":"marketed","mechanism":"ABPO Forte Gel is a topical formulation containing azelaic acid that reduces bacterial colonization and normalizes keratinization to treat acne and rosacea.","indications":["Acne vulgaris","Rosacea"],"catalyst":""},{"name":"AbobotulinumtoxinA dose 1","genericName":"AbobotulinumtoxinA dose 1","slug":"abobotulinumtoxina-dose-1","phase":"phase_2","mechanism":"AbobotulinumtoxinA is a botulinum toxin type A that works by temporarily paralyzing muscles to reduce muscle spasms and improve muscle tone.","indications":["Glabellar lines","Frown lines","Crows feet"],"catalyst":""},{"name":"AbobotulinumtoxinA dose level 1 or 2","genericName":"AbobotulinumtoxinA dose level 1 or 2","slug":"abobotulinumtoxina-dose-level-1-or-2","phase":"phase_2","mechanism":"AbobotulinumtoxinA is a botulinum toxin type A that works by temporarily paralyzing muscle contractions.","indications":["Glabellar lines","Frown lines","Cervical dystonia","Axillary hyperhidrosis"],"catalyst":""},{"name":"Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel","genericName":"Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel","slug":"adapalene-0-1-benzoyl-peroxide-2-5-gel","phase":"phase_3","mechanism":"Adapalene is a retinoid that normalizes skin cell differentiation and reduces inflammation, while benzoyl peroxide kills acne-causing bacteria and provides additional antimicrobial activity.","indications":["Acne vulgaris"],"catalyst":""},{"name":"Adapalene 0.1% and Benzoyl Peroxide 2.5% gel","genericName":"Adapalene 0.1% and Benzoyl Peroxide 2.5% gel","slug":"adapalene-0-1-and-benzoyl-peroxide-2-5-gel","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Adapalene 0.3% / BPO 2.5% gel","genericName":"Adapalene 0.3% / BPO 2.5% gel","slug":"adapalene-0-3-bpo-2-5-gel","phase":"phase_3","mechanism":"Adapalene is a retinoid that normalizes skin cell differentiation and reduces inflammation, while benzoyl peroxide provides antimicrobial activity against acne-causing bacteria.","indications":["Acne vulgaris"],"catalyst":""},{"name":"Adapalene BPO","genericName":"Adapalene BPO","slug":"adapalene-bpo","phase":"phase_3","mechanism":"Adapalene is a retinoid that binds to retinoic acid receptors to normalize skin cell differentiation and reduce inflammation, while benzoyl peroxide provides antimicrobial activity against acne-causing bacteria.","indications":["Acne vulgaris"],"catalyst":""},{"name":"Adapalene Gel, 0.1%","genericName":"Adapalene Gel, 0.1%","slug":"adapalene-gel-0-1","phase":"marketed","mechanism":"Adapalene is a third-generation retinoid that binds to retinoic acid receptors (RARs) to normalize skin cell differentiation and reduce inflammation in acne.","indications":["Acne vulgaris","Photoaging and fine wrinkles (off-label use)"],"catalyst":""},{"name":"Adapalene Gel, 0.1% + Tazarotene Cream, 0.1%","genericName":"Adapalene Gel, 0.1% + Tazarotene Cream, 0.1%","slug":"adapalene-gel-0-1-tazarotene-cream-0-1","phase":"marketed","mechanism":"This combination product delivers two retinoid receptor agonists that normalize skin cell differentiation and reduce inflammation to treat acne and photoaging.","indications":["Acne vulgaris","Photoaging and photodamaged skin"],"catalyst":""},{"name":"Adapalene Lotion Vehicle","genericName":"Adapalene Lotion Vehicle","slug":"adapalene-lotion-vehicle","phase":"phase_3","mechanism":"Adapalene is a third-generation retinoid that binds to retinoic acid receptors to normalize skin cell differentiation and reduce inflammation in acne.","indications":["Acne vulgaris"],"catalyst":""},{"name":"Adapalene/benzoyl peroxide gel, 0.1%/2.5%","genericName":"Adapalene/benzoyl peroxide gel, 0.1%/2.5%","slug":"adapalene-benzoyl-peroxide-gel-0-1-2-5","phase":"marketed","mechanism":"Adapalene is a retinoid that normalizes skin cell differentiation and reduces inflammation, while benzoyl peroxide kills acne-causing bacteria and provides additional antimicrobial activity.","indications":["Acne vulgaris"],"catalyst":""},{"name":"Advanced Eye Relief","genericName":"Advanced Eye Relief","slug":"advanced-eye-relief","phase":"marketed","mechanism":"Advanced Eye Relief is an over-the-counter ophthalmic lubricant and decongestant that reduces eye redness and irritation by moisturizing the ocular surface and constricting blood vessels.","indications":["Minor eye irritation and redness","Dry eye symptoms","Eye discomfort from environmental factors"],"catalyst":""},{"name":"Alluzience","genericName":"Alluzience","slug":"alluzience","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Azzalure or Dysport","genericName":"Azzalure or Dysport","slug":"azzalure-or-dysport","phase":"marketed","mechanism":"Azzalure is a botulinum toxin type A that blocks acetylcholine release at the neuromuscular junction, paralyzing facial muscles and reducing wrinkles.","indications":["Moderate to severe glabellar lines (frown lines between eyebrows)","Moderate to severe lateral canthal lines (crow's feet)","Forehead lines"],"catalyst":""},{"name":"Benzoyl Peroxide Gel 2.5%","genericName":"Benzoyl Peroxide Gel 2.5%","slug":"benzoyl-peroxide-gel-2-5","phase":"phase_3","mechanism":"Benzoyl peroxide kills acne-causing bacteria and promotes skin cell turnover by generating reactive oxygen species.","indications":["Acne vulgaris"],"catalyst":""},{"name":"Betneval ointment - Non-desquamated zone","genericName":"Betneval ointment - Non-desquamated zone","slug":"betneval-ointment-non-desquamated-zone","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Bifonazole Cream","genericName":"Bifonazole Cream","slug":"bifonazole-cream","phase":"marketed","mechanism":"Bifonazole is an imidazole antifungal that disrupts fungal cell membrane integrity by inhibiting ergosterol synthesis.","indications":["Fungal skin infections including dermatophytosis, candidiasis, and pityriasis versicolor","Tinea pedis, tinea corporis, tinea cruris"],"catalyst":""},{"name":"Botulinum Toxin Type A - Vistabel","genericName":"Botulinum Toxin Type A - Vistabel","slug":"botulinum-toxin-type-a-vistabel","phase":"phase_2","mechanism":"Inhibits acetylcholine release at the neuromuscular junction","indications":["Frown lines","Forehead lines","Crow's feet"],"catalyst":""},{"name":"Brimonidine 0.33% gel (Br)","genericName":"Brimonidine 0.33% gel (Br)","slug":"brimonidine-0-33-gel-br","phase":"marketed","mechanism":"Brimonidine is an alpha-2 adrenergic agonist that constricts blood vessels and reduces redness in the skin.","indications":["Persistent facial erythema associated with rosacea"],"catalyst":""},{"name":"C. propionate - Corticosteroid 1","genericName":"C. propionate - Corticosteroid 1","slug":"c-propionate-corticosteroid-1","phase":"phase_3","mechanism":"Clobetasol propionate is a potent topical corticosteroid that suppresses inflammatory and immune responses in the skin by binding to glucocorticoid receptors.","indications":["Inflammatory and pruritic dermatological conditions (e.g., psoriasis, eczema, lichen planus, dermatitis)"],"catalyst":""},{"name":"C. propionate -Corticosteroid 3","genericName":"C. propionate -Corticosteroid 3","slug":"c-propionate-corticosteroid-3","phase":"phase_3","mechanism":"Clobetasol propionate is a potent topical corticosteroid that suppresses inflammatory and immune responses in the skin by binding to glucocorticoid receptors.","indications":["Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., psoriasis, lichen planus, severe eczema)"],"catalyst":""},{"name":"C. propionate- Corticosteroid 2","genericName":"C. propionate- Corticosteroid 2","slug":"c-propionate-corticosteroid-2","phase":"phase_3","mechanism":"Clobetasol propionate is a potent corticosteroid that suppresses inflammatory and immune responses by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.","indications":["Severe inflammatory dermatological conditions (e.g., severe psoriasis, lichen planus, severe eczema)"],"catalyst":""},{"name":"CD 2027","genericName":"CD 2027","slug":"cd-2027","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"CD0271","genericName":"CD0271","slug":"cd0271","phase":"phase_3","mechanism":"CD0271 is a selective inhibitor of phosphodiesterase 4 (PDE4) that reduces inflammatory mediator production in immune cells.","indications":["Atopic dermatitis","Psoriasis"],"catalyst":""},{"name":"CD0271 0.1% / CD1579 2.5%","genericName":"CD0271 0.1% / CD1579 2.5%","slug":"cd0271-0-1-cd1579-2-5","phase":"phase_3","mechanism":"CD0271 and CD1579 are topical agents that work synergistically to reduce skin inflammation and improve dermatological conditions through complementary anti-inflammatory pathways.","indications":["Dermatological inflammatory condition (specific indication not publicly disclosed)"],"catalyst":""},{"name":"CD0271 0.3% / CD1579 2.5%","genericName":"CD0271 0.3% / CD1579 2.5%","slug":"cd0271-0-3-cd1579-2-5","phase":"phase_3","mechanism":"CD0271 and CD1579 are topical agents that work synergistically to reduce inflammation and improve skin barrier function in dermatological conditions.","indications":["Inflammatory dermatological condition (specific indication not publicly disclosed)"],"catalyst":""},{"name":"CD07223","genericName":"CD07223","slug":"cd07223","phase":"phase_2","mechanism":"CD07223 is a small molecule targeting the CD73 enzyme.","indications":["Metastatic melanoma"],"catalyst":""},{"name":"CD07805/47 gel","genericName":"CD07805/47 gel","slug":"cd07805-47-gel","phase":"phase_3","mechanism":"CD07805/47 gel is a topical retinoid that modulates skin cell differentiation and reduces inflammation for acne treatment.","indications":["Acne vulgaris"],"catalyst":""},{"name":"CD07805/47 gel 0.5%/CD07805/47 Vehicle","genericName":"CD07805/47 gel 0.5%/CD07805/47 Vehicle","slug":"cd07805-47-gel-0-5-cd07805-47-vehicle","phase":"phase_3","mechanism":"CD07805/47 is a topical retinoid that modulates retinoid receptor signaling to reduce inflammation and promote skin cell differentiation in dermatological conditions.","indications":["Acne vulgaris","Photoaging/photodamaged skin"],"catalyst":""},{"name":"CD10367 1% Solution - Non-desquamated zone","genericName":"CD10367 1% Solution - Non-desquamated zone","slug":"cd10367-1-solution-non-desquamated-zone","phase":"phase_2","mechanism":"CD10367 is a topical solution designed to treat non-desquamated (non-scaling) skin lesions, likely through anti-inflammatory or keratolytic activity.","indications":["Non-desquamated skin lesions (Phase 2)"],"catalyst":""},{"name":"CD10367 3% Solution - Desquamated zone","genericName":"CD10367 3% Solution - Desquamated zone","slug":"cd10367-3-solution-desquamated-zone","phase":"phase_2","mechanism":"CD10367 3% Solution - Desquamated zone is a topical treatment that helps to remove the outer layer of the skin, reducing the appearance of desquamation.","indications":["Treatment of desquamation"],"catalyst":""},{"name":"CD10367 3% Solution - Non-desquamated zone","genericName":"CD10367 3% Solution - Non-desquamated zone","slug":"cd10367-3-solution-non-desquamated-zone","phase":"phase_2","mechanism":"CD10367 3% Solution - Non-desquamated zone is a topical treatment for acne.","indications":["Acne vulgaris"],"catalyst":""},{"name":"CD11301 0.03%","genericName":"CD11301 0.03%","slug":"cd11301-0-03","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"CD11301 0.06%","genericName":"CD11301 0.06%","slug":"cd11301-0-06","phase":"phase_2","mechanism":"CD11301 is a topical retinoid that modulates the retinoic acid pathway to treat acne.","indications":["Acne vulgaris"],"catalyst":""},{"name":"CD1579 5%","genericName":"CD1579 5%","slug":"cd1579-5","phase":"phase_2","mechanism":"CD1579 5% is a topical retinoid that modulates cell growth and differentiation.","indications":["Acne vulgaris","Photoaging"],"catalyst":""},{"name":"CD5024 0.3% cream","genericName":"CD5024 0.3% cream","slug":"cd5024-0-3-cream","phase":"phase_2","mechanism":"CD5024 0.3% cream is a topical calcineurin inhibitor that suppresses the immune system by inhibiting T-cell activation.","indications":["Atopic dermatitis"],"catalyst":""},{"name":"CD5789 (trifarotene)","genericName":"CD5789 (trifarotene)","slug":"cd5789-trifarotene","phase":"phase_3","mechanism":"Trifarotene is a selective retinoid X receptor (RXR) agonist that modulates gene expression to reduce inflammation and promote skin cell differentiation.","indications":["Psoriasis","Atopic dermatitis"],"catalyst":""},{"name":"Calcipotriene and betamethasone dipropionate ointment","genericName":"Calcipotriene and betamethasone dipropionate ointment","slug":"calcipotriene-and-betamethasone-dipropionate-ointment","phase":"marketed","mechanism":"This combination ointment uses calcipotriene (a vitamin D analog) to normalize skin cell differentiation and betamethasone dipropionate (a potent corticosteroid) to reduce inflammation and immune activation in psoriatic plaques.","indications":["Plaque psoriasis","Psoriatic dermatitis"],"catalyst":""},{"name":"Ciclopirox NL","genericName":"Ciclopirox NL","slug":"ciclopirox-nl","phase":"marketed","mechanism":"Ciclopirox is a broad-spectrum antifungal agent that inhibits fungal enzyme systems by chelating polyvalent cations, disrupting cellular respiration and biosynthesis.","indications":["Onychomycosis (fungal nail infection)","Tinea pedis (athlete's foot)","Tinea corporis (ringworm)","Tinea cruris (jock itch)","Candidiasis (yeast infections)"],"catalyst":""},{"name":"Clobetasol Propionate 0.05% Foam","genericName":"Clobetasol Propionate 0.05% Foam","slug":"clobetasol-propionate-0-05-foam","phase":"marketed","mechanism":"Clobetasol propionate is a potent topical corticosteroid that suppresses inflammatory and immune responses in the skin by binding to glucocorticoid receptors.","indications":["Inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses (scalp and body)","Psoriasis","Eczema","Lichen planus","Other steroid-responsive dermatologic conditions"],"catalyst":""},{"name":"Clobetasol Propionate, 0.05%","genericName":"Clobetasol Propionate, 0.05%","slug":"clobetasol-propionate-0-05","phase":"marketed","mechanism":"Clobetasol propionate is a potent corticosteroid that suppresses inflammatory and immune responses by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.","indications":["Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., psoriasis, lichen planus, severe eczema)","Alopecia areata","Lichen sclerosus"],"catalyst":""},{"name":"Clobex® Vehicle Shampoo","genericName":"Clobex® Vehicle Shampoo","slug":"clobex-vehicle-shampoo","phase":"phase_3","mechanism":"Clobex Vehicle Shampoo delivers clobetasol propionate, a potent topical corticosteroid, to the scalp to reduce inflammation and suppress immune-mediated skin responses.","indications":["Inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp"],"catalyst":""},{"name":"Corticosteroid 1- C. propionate","genericName":"Corticosteroid 1- C. propionate","slug":"corticosteroid-1-c-propionate","phase":"phase_3","mechanism":"Clobetasol propionate is a potent corticosteroid that suppresses inflammatory and immune responses by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.","indications":["Severe inflammatory dermatological conditions (e.g., severe psoriasis, lichen planus, severe eczema)","Short-term treatment of severe corticosteroid-responsive dermatoses"],"catalyst":""},{"name":"Corticosteroid 2 - C. propionate","genericName":"Corticosteroid 2 - C. propionate","slug":"corticosteroid-2-c-propionate","phase":"phase_3","mechanism":"Clobetasol propionate is a potent corticosteroid that suppresses inflammatory and immune responses by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.","indications":["Severe inflammatory dermatological conditions (e.g., severe psoriasis, lichen planus, severe eczema)"],"catalyst":""},{"name":"Corticosteroid 3 - C. propionate","genericName":"Corticosteroid 3 - C. propionate","slug":"corticosteroid-3-c-propionate","phase":"phase_3","mechanism":"Clobetasol propionate is a potent corticosteroid that suppresses inflammatory and immune responses by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.","indications":["Severe inflammatory dermatological conditions (e.g., severe psoriasis, lichen planus, severe eczema)","Short-term treatment of severe dermatitis and pruritic conditions"],"catalyst":""},{"name":"Drug: CD07805/47 gel","genericName":"Drug: CD07805/47 gel","slug":"drug-cd07805-47-gel","phase":"phase_3","mechanism":"CD07805/47 gel is a topical retinoid that promotes skin cell turnover and collagen remodeling to improve signs of photoaging and wrinkles.","indications":["Photoaged skin and facial wrinkles"],"catalyst":""},{"name":"Facial Cleanser and Moisturizer SPF 30","genericName":"Facial Cleanser and Moisturizer SPF 30","slug":"facial-cleanser-and-moisturizer-spf-30","phase":"marketed","mechanism":"This topical product provides physical and chemical sun protection while cleansing and moisturizing the facial skin.","indications":["Daily facial cleansing and sun protection (SPF 30)"],"catalyst":""},{"name":"Facial Moisturizer with SPF 50+","genericName":"Facial Moisturizer with SPF 50+","slug":"facial-moisturizer-with-spf-50","phase":"marketed","mechanism":"This product provides physical and chemical UV protection to prevent sun damage while delivering hydration to facial skin.","indications":["Sun protection and photoaging prevention","Daily facial moisturization with UV protection"],"catalyst":""},{"name":"Ivermectin 1% cream (IVM)","genericName":"Ivermectin 1% cream (IVM)","slug":"ivermectin-1-cream-ivm","phase":"marketed","mechanism":"Ivermectin binds to glutamate-gated chloride channels in parasites and arthropods, causing paralysis and death of the organisms.","indications":["Rosacea (topical)","Scabies (topical)"],"catalyst":""},{"name":"Lidocaine 7% + Tetracaine 7% cream","genericName":"Lidocaine 7% + Tetracaine 7% cream","slug":"lidocaine-7-tetracaine-7-cream","phase":"marketed","mechanism":"Lidocaine and tetracaine are local anesthetics that block sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses to produce topical anesthesia.","indications":["Topical anesthesia for dermatological procedures (e.g., laser treatment, chemical peels, microdermabrasion)","Numbing prior to minor surgical procedures on skin"],"catalyst":""},{"name":"Loceryl NL","genericName":"Loceryl NL","slug":"loceryl-nl","phase":"marketed","mechanism":"Loceryl is an antifungal nail lacquer that inhibits fungal cell wall synthesis by disrupting ergosterol production.","indications":["Onychomycosis (fungal nail infection)"],"catalyst":""},{"name":"Loceryl NL + Cosmetic varnish","genericName":"Loceryl NL + Cosmetic varnish","slug":"loceryl-nl-cosmetic-varnish","phase":"marketed","mechanism":"Amorolfine is a morpholine antifungal that inhibits fungal sterol synthesis by blocking both Δ14-reductase and Δ8-Δ7-isomerase enzymes in the ergosterol biosynthesis pathway.","indications":["Onychomycosis (fungal nail infection)"],"catalyst":""},{"name":"Loceryl NL 12 weeks","genericName":"Loceryl NL 12 weeks","slug":"loceryl-nl-12-weeks","phase":"marketed","mechanism":"Loceryl is a topical antifungal that inhibits fungal sterol synthesis by blocking lanosterol 14α-demethylase, disrupting the fungal cell membrane.","indications":["Onychomycosis (fungal nail infection)","Dermatophyte and yeast infections of nails"],"catalyst":""},{"name":"Loceryl NL 15 months","genericName":"Loceryl NL 15 months","slug":"loceryl-nl-15-months","phase":"marketed","mechanism":"Amorolfine is a morpholine antifungal that inhibits fungal sterol synthesis by blocking both Δ14-reductase and Δ8-Δ7-isomerase enzymes in the ergosterol biosynthesis pathway.","indications":["Onychomycosis (fungal nail infection) of toenails and fingernails"],"catalyst":""},{"name":"Loceryl Nail Lacquer","genericName":"Loceryl Nail Lacquer","slug":"loceryl-nail-lacquer","phase":"marketed","mechanism":"Amorolfine inhibits fungal sterol synthesis by blocking lanosterol demethylase, disrupting the integrity of the fungal cell membrane.","indications":["Onychomycosis (fungal nail infection) caused by dermatophytes, yeasts, and non-dermatophyte molds"],"catalyst":""},{"name":"MAL 16.8% cream","genericName":"MAL 16.8% cream","slug":"mal-16-8-cream","phase":"phase_3","mechanism":"MAL 16.8% cream is a topical formulation of methyl aminolevulinate that generates reactive oxygen species upon light activation to destroy abnormal skin cells.","indications":["Actinic keratosis (field treatment)","Basal cell carcinoma (superficial and nodular)"],"catalyst":""},{"name":"MAL Vehicle Cream","genericName":"MAL Vehicle Cream","slug":"mal-vehicle-cream","phase":"phase_3","mechanism":"MAL Vehicle Cream is a topical formulation vehicle designed to deliver active pharmaceutical ingredients through the skin for localized therapeutic effect.","indications":["Topical delivery vehicle for dermatological applications (specific indication dependent on active ingredient formulated with this vehicle)"],"catalyst":""},{"name":"Methyl Aminolaevulinate 16% Cream","genericName":"Methyl Aminolaevulinate 16% Cream","slug":"methyl-aminolaevulinate-16-cream","phase":"marketed","mechanism":"Methyl aminolaevulinate is a photosensitizing prodrug that accumulates in abnormal skin cells and generates reactive oxygen species when activated by red light, destroying target lesions.","indications":["Actinic keratosis (non-hyperkeratotic, non-pigmented lesions on face and scalp)","Basal cell carcinoma (superficial and nodular types)"],"catalyst":""},{"name":"Metronidazole 0.75% cream","genericName":"Metronidazole 0.75% cream","slug":"metronidazole-0-75-cream","phase":"phase_3","mechanism":"Metronidazole disrupts bacterial and protozoal DNA, leading to cell death and reduction of microorganisms associated with rosacea and other inflammatory skin conditions.","indications":["Rosacea (topical treatment)","Bacterial vaginosis (systemic formulations; topical cream may be used off-label)"],"catalyst":""},{"name":"Metronidazole gel 1%","genericName":"Metronidazole gel 1%","slug":"metronidazole-gel-1","phase":"marketed","mechanism":"Metronidazole disrupts bacterial and protozoal DNA by generating reactive oxygen species and damaging nucleic acids, leading to cell death.","indications":["Rosacea (topical)","Bacterial vaginosis (topical)","Perioral dermatitis (topical)"],"catalyst":""},{"name":"Metvix and conventional PDT","genericName":"Metvix and conventional PDT","slug":"metvix-and-conventional-pdt","phase":"phase_3","mechanism":"Metvix is a photosensitizing agent that accumulates in abnormal skin cells and, when activated by light in photodynamic therapy (PDT), generates reactive oxygen species to destroy lesions.","indications":["Actinic keratosis","Basal cell carcinoma","Bowen's disease"],"catalyst":""},{"name":"Metvix and natural daylight PDT","genericName":"Metvix and natural daylight PDT","slug":"metvix-and-natural-daylight-pdt","phase":"phase_3","mechanism":"Metvix (methyl aminolevulinate) is a photosensitizing agent that accumulates in abnormal skin cells and is activated by natural daylight to generate reactive oxygen species that destroy lesions.","indications":["Actinic keratosis (field treatment with daylight PDT)","Non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma)"],"catalyst":""},{"name":"Metvix cream","genericName":"Metvix cream","slug":"metvix-cream","phase":"phase_3","mechanism":"Metvix (methyl aminolevulinate) is a photosensitizing agent that accumulates in abnormal cells and generates reactive oxygen species when activated by light, destroying target lesions.","indications":["Actinic keratosis","Basal cell carcinoma (superficial and nodular)","Bowen's disease"],"catalyst":""},{"name":"NDL-PDT","genericName":"NDL-PDT","slug":"ndl-pdt","phase":"phase_3","mechanism":"NDL-PDT is a photodynamic therapy agent that generates reactive oxygen species upon light activation to destroy targeted tissue.","indications":["Actinic keratosis","Non-melanoma skin cancer"],"catalyst":""},{"name":"Oracea","genericName":"Oracea","slug":"oracea","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Oral doxycycline hyclate","genericName":"Oral doxycycline hyclate","slug":"oral-doxycycline-hyclate","phase":"marketed","mechanism":"Doxycycline hyclate is a tetracycline antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit.","indications":["Bacterial infections (respiratory, urinary, skin, soft tissue)","Acne vulgaris","Rosacea","Malaria prophylaxis","Lyme disease"],"catalyst":""},{"name":"Product B","genericName":"Product B","slug":"product-b","phase":"marketed","mechanism":"Product B is a marketed dermatological agent from Galderma R&D, but specific mechanistic details are not publicly available.","indications":[],"catalyst":""},{"name":"QM1114-DP","genericName":"QM1114-DP","slug":"qm1114-dp","phase":"phase_3","mechanism":"QM1114-DP is a topical treatment that targets the inflammatory pathways in the skin.","indications":["Acne vulgaris"],"catalyst":""},{"name":"Retin-A Micro Microsphere 0.1%","genericName":"Retin-A Micro Microsphere 0.1%","slug":"retin-a-micro-microsphere-0-1","phase":"marketed","mechanism":"Retin-A Micro delivers tretinoin (a vitamin A derivative) in microsphere form to normalize skin cell turnover and reduce comedone formation.","indications":["Acne vulgaris","Photoaged skin (fine wrinkles, mottled hyperpigmentation, roughness)"],"catalyst":""},{"name":"Trifarotene Vehicle","genericName":"Trifarotene Vehicle","slug":"trifarotene-vehicle","phase":"marketed","mechanism":"Trifarotene is a selective retinoid X receptor (RXR) agonist that modulates gene expression to reduce inflammation and normalize skin cell differentiation in acne.","indications":["Acne vulgaris"],"catalyst":""},{"name":"Trifarotene cream","genericName":"Trifarotene cream","slug":"trifarotene-cream","phase":"marketed","mechanism":"Trifarotene is a selective retinoid X receptor (RXR) agonist that modulates gene expression to reduce inflammation and normalize skin cell differentiation in acne.","indications":["Acne vulgaris"],"catalyst":""},{"name":"adapalen 0.1%","genericName":"adapalen 0.1%","slug":"adapalen-0-1","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"adapalene cream 0.1% and adapalene lotion 0.1%","genericName":"adapalene cream 0.1% and adapalene lotion 0.1%","slug":"adapalene-cream-0-1-and-adapalene-lotion-0-1","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"adapalene gel, 0.3%","genericName":"adapalene gel, 0.3%","slug":"adapalene-gel-0-3","phase":"marketed","mechanism":"Adapalene is a third-generation retinoid that binds to retinoic acid receptors (RARs) to normalize skin cell differentiation and reduce inflammation.","indications":["Acne vulgaris","Photoaging and fine wrinkles (off-label use in some regions)"],"catalyst":""},{"name":"adapalene lotion 0.1%","genericName":"adapalene lotion 0.1%","slug":"adapalene-lotion-0-1","phase":"phase_3","mechanism":"Adapalene is a topical retinoid that works by binding to retinoic acid receptors, modulating gene expression and promoting cell turnover.","indications":["Acne vulgaris","Aging skin"],"catalyst":""},{"name":"adapalene/benzoyl peroxide","genericName":"adapalene/benzoyl peroxide","slug":"adapalene-benzoyl-peroxide","phase":"marketed","mechanism":"Adapalene is a retinoid that normalizes skin cell differentiation and reduces inflammation, while benzoyl peroxide is an antimicrobial that kills acne-causing bacteria and reduces sebum production.","indications":["Acne vulgaris"],"catalyst":""},{"name":"azelaic acid 15% gel","genericName":"azelaic acid 15% gel","slug":"azelaic-acid-15-gel","phase":"marketed","mechanism":"Azelaic acid reduces bacterial colonization and normalizes keratinization while exerting anti-inflammatory and antimicrobial effects on the skin.","indications":["Acne vulgaris","Rosacea","Post-inflammatory hyperpigmentation"],"catalyst":""},{"name":"botulinum toxin neuromodulator","genericName":"botulinum toxin neuromodulator","slug":"botulinum-toxin-neuromodulator","phase":"phase_3","mechanism":"Botulinum toxin blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.","indications":["Chronic migraine","Cervical dystonia","Blepharospasm","Hyperhidrosis","Spasticity"],"catalyst":""},{"name":"c-PDT","genericName":"c-PDT","slug":"c-pdt","phase":"phase_3","mechanism":"c-PDT is a photodynamic therapy approach that uses a photosensitizing agent activated by light to generate reactive oxygen species and destroy target cells.","indications":["Actinic keratosis","Non-melanoma skin cancer"],"catalyst":""},{"name":"ketoconazole shampoo (2/week)","genericName":"ketoconazole shampoo (2/week)","slug":"ketoconazole-shampoo-2-week","phase":"phase_3","mechanism":"Ketoconazole shampoo inhibits fungal growth by disrupting ergosterol synthesis in fungal cell membranes, reducing dandruff and seborrheic dermatitis.","indications":["Dandruff and seborrheic dermatitis of the scalp"],"catalyst":""},{"name":"powder BoNT-A (BOTOX/Vistabel)","genericName":"powder BoNT-A (BOTOX/Vistabel)","slug":"powder-bont-a-botox-vistabel","phase":"marketed","mechanism":"Botulinum toxin type A blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.","indications":["Moderate to severe glabellar lines (frown lines) in adults","Moderate to severe lateral canthal lines (crow's feet) in adults","Forehead lines in adults","Cervical dystonia","Chronic migraine"],"catalyst":""},{"name":"tretinoin 0.05% emollient cream","genericName":"tretinoin 0.05% emollient cream","slug":"tretinoin-0-05-emollient-cream","phase":"phase_3","mechanism":"Tretinoin is a retinoid that promotes skin cell turnover and reduces acne by unclogging pores.","indications":["Acne vulgaris","Fine wrinkles associated with photoaging"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPTWdkLXZqTVBOSkpkbFA0WHcyVzNqT0NVcTExN0ZsaDQxMnUxaHE2SDlRZUZ0UW04NWlhSkdCNDZWaEtoVzlrWnpGRi1hYUpQNzJlQnkyOUdXVlFEaDk2dlVfczVibXVHRXRaZTBERzdUMGl4MDBFVHZlNm1aTmQtck51aFdXYmlRdm5SOVFWdUJabjFwVnVpWGpWQnRldw?oc=5","date":"2026-04-08","type":"pipeline","source":"openPR.com","summary":"Acne Treatment Market Size in the 7MM is projected to grow at a significant CAGR by 2032, estimates DelveInsight - openPR.com","headline":"Acne Treatment Market Size in the 7MM is projected to grow at a significant CAGR by 2032, estimates DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQd1BSdGNva0tpWmhrQ0lfb0F3M3JGX093cTRZczBURnhXVmkwU1VFenJVcndjM1o5X1dVc3YtekpmczhDdHVTSUJ1V3BGdUpvNHdyZElfZjh3V291MEhiYWFqNHp6NDRJZE12ZmRIR1EtajFndjJEUjVXYjJQNENUcnlvZ3FQR21mRHI5Uk9hNFc4U0RZc0Z1bmNB?oc=5","date":"2026-04-07","type":"regulatory","source":"openPR.com","summary":"Chronic Plaque Psoriasis Market Size is to Show Remarkable Growth Trends from 2024 to 2034, estimates DelveInsight - openPR.com","headline":"Chronic Plaque Psoriasis Market Size is to Show Remarkable Growth Trends from 2024 to 2034, estimates DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxOVEZ2eFBzeXVxbHpYVDhyTnVhVXliLWhHSlVnU1ZTU2FRaGxnWEM3MDJFejdYcGFVd0I3cWh1TEJldXhjZEVPZUM3Y1phbVY2cXZ5Yk53aUljLWtjZTYtOHVzS2h3T2FQbkRFZjJ1RGFYMjZ4aDM0elNsdDRweTA0ekU2dHJPYWVzSlptWUZQeFVOQmx5QnlYVnFOeGVnQkRkWjIxTjNib1VyVjhQQ0pQeFBKc3puakJTbm5sM2lJRUl0WGJZSHFiOEwxNVEtanpDTHhkWGptb0ZlazROZHFiMjVzRVVCenpaVUcwMWRPUlYzQUU?oc=5","date":"2026-02-02","type":"regulatory","source":"businesswire.com","summary":"Galderma Announces U.S. FDA Acceptance of RelabotulinumtoxinA Biologics License Application Resubmission - businesswire.com","headline":"Galderma Announces U.S. FDA Acceptance of RelabotulinumtoxinA Biologics License Application Resubmission","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOQ0FiN0FuVlVKN3d1bUZhYS0tdjhFakQ1a0l2U2JCTmtBNEF1TWljRE9zUUNHXzhfSnc1akdOUVVKRFdXRzR1elJFSi11TnFvd3F5Q0pidEJ3NWtwN3EyT1MzRnJTUmszcy1uZVFENmFzRXFKUk5RaFBnOHpidlJDSWNoMmt4dw?oc=5","date":"2026-01-30","type":"pipeline","source":"Yahoo Finance","summary":"Galderma Group (SWX:GALD) Valuation Check After Recent Share Price Weakness And R&D Driven Growth Hopes - Yahoo Finance","headline":"Galderma Group (SWX:GALD) Valuation Check After Recent Share Price Weakness And R&D Driven Growth Hopes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5kN1ZqWHphaGNxNmlNcWZwMkpXa2RvZmRSRkwzaFJjSmdvWkpmS2JqY2dlTzJvWDhKSy1qTjh2R2RHaUNmN3FUb1BIWkI0Yy1WRGhuOGl5VlBaTUhzRE1veTBfRDQtR3NRblZLMTNR0gFyQVVfeXFMTlhMMTA5MTk2eDVQMmZHVWxVY2c2SFh4SWJiRXM1TmJDR1hkRDNkZUJkQVhUWVg1bXBhVUUxZVU4RThPWUVsNGQzVWlRX3NFeXFvcFd1RGQxSzhPLWdsc2U1WThBQjV4ekQ4cjB5akNoY1Jn?oc=5","date":"2026-01-26","type":"pipeline","source":"koreabiomed.com","summary":"Galderma aims to shake up Korea’s dermatology biologics market with Nemluvio - koreabiomed.com","headline":"Galderma aims to shake up Korea’s dermatology biologics market with Nemluvio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPOEU4Z2g3cjJxYkZvT19YUmVMX1BUem9rWTRvOHRxdUtad0ctcldFdWc4OE5MUVR4cUFMcDhfY1pKbEhpN2xOdDVmMUU3U1VoQzY4eUY3azNGUnVDeVFuNDJEc2UwTTdsY3lzSUw5d2cxSktWMG1SRU02cGRodDg0cXNITWM4UTQ2cUp6bG9Xd0dOODI0LXoxWmZaMUtyMFlKNTVJM2J5SXZSSGJnajh0b09ScjV1Zw?oc=5","date":"2026-01-22","type":"pipeline","source":"The Pharma Letter","summary":"Tribunal upholds Ipsen’s termination of R&D agreement with Galderma - The Pharma Letter","headline":"Tribunal upholds Ipsen’s termination of R&D agreement with Galderma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNU3c4Z3NvN20tdk9uME9KTzFicXpfMkNXWmc1WWpHR3R3RlZic1pVLXFDUmJtdW52VU45TmR6RHVLTUk2dGFHQ3BkRmNGRF95dExMWi1vQTFORTdXU0ttT2oxb3NET0V1SDhLX293Sy1UYUdKY0E0aldMRjY5Y0tCVXY4alM2VmloWWcxU1BzT0xYeXF4UnVz?oc=5","date":"2026-01-21","type":"pipeline","source":"Yahoo Finance","summary":"Arbitration tribunal upholds Ipsen’s termination of R&D agreement with Galderma - Yahoo Finance","headline":"Arbitration tribunal upholds Ipsen’s termination of R&D agreement with Galderma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPWUd6RHBCekljU19vZXFoMTZBOXE4T0VRc0xWRUpWNFN1VmlKaU1mU0NCbUc5QUo4a1ZUR18teDZXcEJjUnRVejNRQW1qdlNrTGtHQUZIQU1mdzE0dEJtZzdla3hFX21mQ0EwNWotUEtqWVptUmJPWDZmRzNSRVdvemRNeHBaank5elVXZ0w4N1duREYxNU9CUTNWQWxxWl91dWc4?oc=5","date":"2026-01-21","type":"pipeline","source":"marketscreener.com","summary":"Ipsen Prevails in Legal Dispute Against Galderma - marketscreener.com","headline":"Ipsen Prevails in Legal Dispute Against Galderma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxPS2xSSXdOelZKT0VqWjZpcXJGaUtRR1VmNTc0ZEJHVWlVSk9MX184NmRxSl9YQU92X2dMbENoS1J1ay1Pd19OOENzRlpDU1Y1ZUdjcWlibERCUmNvX2ctMFJGbGJLc2NLUm1vZEs0U1VjTDc5bHZnSDN2TktjXzV4MnBTdWhha0Nsa3dLSVpPS2hDZ3FKakwyZzNPN182X2NNWkZGRHB6NHF5X0lPU3FWU2IyRkFzZ0RBWDdiY0hLWENqNVR1THo5WFRHV0JDTzRZTkR5RC1OdVJJTWFDcWZVd1ZvOUlMN3FwWm5aZEtmUGZIV1p3SHo1S205Qy1tMWkya0E?oc=5","date":"2026-01-15","type":"pipeline","source":"BioSpace","summary":"TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics - BioSpace","headline":"TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injecta","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPX2NMWUNiVFRZZzRKZmR4NklFOWhSWWxkQ3VWeTBibzZkYkpQTzE1a1RCUFJiUlNyMmc1Sk9LaGlqb2RrWlMwRDNyZ0k5bUNkbWJFTmY0NUZ5WV9kY2JQblFieUI3WDhDZ09UbEc2SDI5UmUxT0lpQTlNY3ZOeTdhc205S3BMWW8zVGc2SXJzUkJOOXBRUnRwV1pEbXFoVzdmanhkNVVQbS12NS0xS2Nz?oc=5","date":"2025-10-23","type":"pipeline","source":"Fierce Pharma","summary":"With Nemluvio sales booming, Galderma pledges to spend $650M on US-based manufacturing - Fierce Pharma","headline":"With Nemluvio sales booming, Galderma pledges to spend $650M on US-based manufacturing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOeHYxNU9BTXpHNE01YzRBQ0VJTWRPTmYyMVJqbGI5YTVhbzh3OGpJUzN0dmRmWTAtUktHd2hpNnJDQ19YRTFOOWh1ZVdoZHRzWkVQc19VaWRJY2I3MUhFWHRBTUQyeEg3VjdVaWlmbUFSZDBiX3hxbXBtTFRzQ25NejRpNFRsc0dLWlVRUHZPN1hkamtfb2tsdk44NFBLejQ5NjhlakxfVDJ5b3M?oc=5","date":"2025-06-11","type":"pipeline","source":"PMLiVE","summary":"Galderma shares positive two-year results for Nemluvio in atopic dermatitis - PMLiVE","headline":"Galderma shares positive two-year results for Nemluvio in atopic dermatitis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNYzZ6Ul80Wjk3bVVydzE5Mk5jT3plcnRWNlliRWRUX3FKOUZBQXVQUEZnRy01RU9NdzdzMXhManZrMEpwRmJPN24wcUt0OWtFRUVhekRZY3JhQ2s1N0swUjBrb25uRUswQlZmNGhJOTBTN2hrMGZaR3h5bmpLQTUwbXlIQlRsMGFwLXNueWNnQ0pJVi1PLUE?oc=5","date":"2024-08-13","type":"regulatory","source":"BioPharma Dive","summary":"Galderma wins FDA approval for skin condition treatment - BioPharma Dive","headline":"Galderma wins FDA approval for skin condition treatment","sentiment":"positive"}],"patents":[],"drugCount":95,"phaseCounts":{"marketed":44,"phase_3":36,"phase_2":14,"phase_1":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}